BPA Call HT001419A0035-HT001422F0028
Award Date
11/22/21
Potential Completion Date
11/21/22
Potential Value
$100K
Federal Agency
Defense Health Agency
Awardee
Cell Marque Corp
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rocklin, CA 95677, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Cell Marque Corporation on November 6, 2019 for the delivery of antibodies and kits for the agency's Pathology Department. With a potential value of $78,882.58, the contract has a completion date of November 5, 2020 and does not have a set-aside designation. Cell Marque Corporation will deliver the requested products from their facility located in Bethesda, Maryland to support the...
The Defense Health Agency Contracting Activity awarded a firm fixed-price purchase order contract worth $45,801.00 to Cell Marque Corporation, a manufacturer of antibodies and reagents for in vitro diagnostic use. The contract is for the supply of various Cell Marque antibodies to support immunohistochemical testing using Ventana BenchMark autostainers at the Naval Medical Center San Diego's Laboratory Department. This appears to be a sole source award, as the government determined that Cell...
<p>Cell Marque Corporation was awarded a $100,000 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents and supplies. The contract has a period of performance through November 2021 for products to be delivered to locations in Bethesda, Maryland. No set-aside provisions were applied to this award made by the agency to support its medical research and healthcare programs.</p>
The Defense Health Agency (DOD) awarded a $250,000 Blanket Purchase Agreement Call contract to Roche Diagnostics Corporation to provide reagents and consumable supplies for the Walter Reed National Military Center in Bethesda, Maryland. The firm fixed price contract runs from November 19, 2021 through January 18, 2022 and will be performed at the Walter Reed location. Roche Diagnostics Corporation will directly supply reagents and consumable laboratory supplies as the prime contractor to support...
Roche Diagnostics Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at approximately $246,000 by the Defense Health Agency to provide supplies and consumables for the Anatomic Pathology Laboratory at Walter Reed National Military Medical Center in Bethesda, Maryland. The contract has no set-aside designation and runs through July 25, 2022. Roche Diagnostics will deliver the requested medical laboratory products and services to support...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Biocare Medical LLC, a manufacturer of immunohistochemistry (IHC) products. The $25,000 call is for the procurement of specialized reagents and peripheral consumables, including those for Treponema pallidum, smoothelin, and amyloid testing. This is an existing single-award BPA between Biocare Medical and the Department of the Army Medical Command, with a potential total value of $187,800...
This federal contract award was made by the Defense Health Agency to Biocare Medical LLC, a for-profit limited liability company and manufacturer of medical equipment and supplies. The $35,000 firm fixed-price contract is for the provision of REAGENTS AND PERIPHERAL items and is structured as a blanket purchase agreement (BPA) call. The contract does not have a set-aside designation. Biocare Medical LLC is an experienced federal contractor, having secured multiple awards from agencies such as...
<p>The Defense Health Agency (DOD) awarded Roche Diagnostics Corporation a $500,000 Blanket Purchase Agreement (BPA) Call contract to provide Roche reagents. The contract has a place of performance in Bethesda, Maryland and runs from December 21, 2021 through December 22, 2022 with a Firm Fixed Price pricing structure. Roche Diagnostics Corporation will serve as the prime contractor to supply reagents to the Defense Health Agency, supporting its medical testing needs.</p>
Roche Diagnostics Corporation has been awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at thirteen thousand seven hundred sixty-three dollars and fifty-four cents ($13,763.54) by the Defense Health Agency to provide biopsy reagents. The contract has no set-aside designation and requires completion of the ordered products and services by September 30, 2022. As the healthcare arm of the Department of Defense, this award indicates the Defense Health Agency will...
This contract was awarded by the Defense Health Agency (DHA) to One Lambda, Inc., a for-profit manufacturer of medical testing reagents, kits, and related products. The $212,305.29 firm-fixed-price contract is for the delivery of medical supplies to the Walter Reed National Military Medical Center. The award is not set-aside and represents a Blanket Purchase Agreement (BPA) call order, with a completion date of March 20, 2024. One Lambda, Inc. is a subsidiary of Thermo Electron Corporation and...